annual EBIT:
-$196.13M+$370.80M(+65.41%)Summary
- As of today (May 19, 2025), PTCT annual earnings before interest & taxes is -$196.13 million, with the most recent change of +$370.80 million (+65.41%) on December 31, 2024.
- During the last 3 years, PTCT annual EBIT has risen by +$236.19 million (+54.63%).
- PTCT annual EBIT is now -741.31% below its all-time high of $30.58 million, reached on December 31, 2011.
Performance
PTCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$963.92M+$1.02B(+1897.05%)Summary
- As of today (May 19, 2025), PTCT quarterly earnings before interest & taxes is $963.92 million, with the most recent change of +$1.02 billion (+1897.05%) on March 1, 2025.
- Over the past year, PTCT quarterly EBIT has increased by +$1.01 billion (+2297.62%).
- PTCT quarterly EBIT is now at all-time high.
Performance
PTCT quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$811.66M+$1.01B(+513.84%)Summary
- As of today (May 19, 2025), PTCT TTM earnings before interest & taxes is $811.66 million, with the most recent change of +$1.01 billion (+513.84%) on March 1, 2025.
- Over the past year, PTCT TTM EBIT has increased by +$1.31 billion (+261.32%).
- PTCT TTM EBIT is now at all-time high.
Performance
PTCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PTCT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.4% | +2297.6% | +261.3% |
| 3 y3 years | +54.6% | +1079.8% | +292.5% |
| 5 y5 years | +13.8% | +1002.4% | +406.3% |
PTCT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.4% | at high | +563.3% | at high | +231.1% |
| 5 y | 5-year | at high | +65.4% | at high | +563.3% | at high | +231.1% |
| alltime | all time | -741.3% | +65.4% | at high | +563.3% | at high | +231.1% |
PTCT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $963.92M(-1897.1%) | $811.66M(-513.8%) |
| Dec 2024 | -$196.13M(-65.4%) | -$53.64M(-4.9%) | -$196.13M(-23.2%) |
| Sep 2024 | - | -$56.38M(+33.5%) | -$255.26M(-24.3%) |
| Jun 2024 | - | -$42.24M(-3.7%) | -$337.31M(-33.0%) |
| Mar 2024 | - | -$43.86M(-61.1%) | -$503.13M(-11.3%) |
| Dec 2023 | -$566.93M(+14.2%) | -$112.78M(-18.5%) | -$566.93M(-8.5%) |
| Sep 2023 | - | -$138.43M(-33.5%) | -$619.35M(+5.5%) |
| Jun 2023 | - | -$208.06M(+93.3%) | -$587.24M(+16.1%) |
| Mar 2023 | - | -$107.66M(-34.8%) | -$505.90M(+1.9%) |
| Dec 2022 | -$496.62M(+14.9%) | -$165.19M(+55.4%) | -$496.62M(+11.0%) |
| Sep 2022 | - | -$106.33M(-16.1%) | -$447.53M(-1.2%) |
| Jun 2022 | - | -$126.72M(+28.8%) | -$453.06M(+7.4%) |
| Mar 2022 | - | -$98.38M(-15.3%) | -$421.66M(-2.5%) |
| Dec 2021 | -$432.32M(+24.7%) | -$116.11M(+3.8%) | -$432.32M(+22.2%) |
| Sep 2021 | - | -$111.86M(+17.3%) | -$353.64M(+31.9%) |
| Jun 2021 | - | -$95.32M(-12.6%) | -$268.15M(-23.1%) |
| Mar 2021 | - | -$109.03M(+191.3%) | -$348.79M(+0.6%) |
| Dec 2020 | -$346.58M(+52.4%) | -$37.43M(+42.0%) | -$346.58M(-6.5%) |
| Sep 2020 | - | -$26.36M(-85.0%) | -$370.72M(-7.8%) |
| Jun 2020 | - | -$175.96M(+64.7%) | -$402.03M(+51.7%) |
| Mar 2020 | - | -$106.82M(+73.5%) | -$265.01M(+16.5%) |
| Dec 2019 | -$227.44M(+96.8%) | -$61.57M(+6.8%) | -$227.44M(+7.9%) |
| Sep 2019 | - | -$57.67M(+48.1%) | -$210.87M(+4.7%) |
| Jun 2019 | - | -$38.94M(-43.8%) | -$201.43M(+19.9%) |
| Mar 2019 | - | -$69.25M(+53.9%) | -$168.06M(+45.4%) |
| Dec 2018 | -$115.56M | -$45.01M(-6.7%) | -$115.56M(+77.5%) |
| Sep 2018 | - | -$48.23M(+765.3%) | -$65.10M(+36.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$5.57M(-66.7%) | -$47.76M(-12.7%) |
| Mar 2018 | - | -$16.74M(-407.2%) | -$54.68M(-15.0%) |
| Dec 2017 | -$64.29M(-51.3%) | $5.45M(-117.6%) | -$64.29M(-32.1%) |
| Sep 2017 | - | -$30.89M(+147.2%) | -$94.74M(-1.2%) |
| Jun 2017 | - | -$12.50M(-52.6%) | -$95.91M(-20.1%) |
| Mar 2017 | - | -$26.36M(+5.5%) | -$119.97M(-9.2%) |
| Dec 2016 | -$132.06M(-21.0%) | -$24.99M(-22.1%) | -$132.06M(-14.9%) |
| Sep 2016 | - | -$32.06M(-12.3%) | -$155.27M(-6.1%) |
| Jun 2016 | - | -$36.56M(-4.9%) | -$165.44M(-1.2%) |
| Mar 2016 | - | -$38.44M(-20.2%) | -$167.50M(+0.2%) |
| Dec 2015 | -$167.13M(+68.1%) | -$48.20M(+14.1%) | -$167.13M(+10.6%) |
| Sep 2015 | - | -$42.23M(+9.3%) | -$151.16M(+10.7%) |
| Jun 2015 | - | -$38.63M(+1.5%) | -$136.53M(+10.8%) |
| Mar 2015 | - | -$38.07M(+18.1%) | -$123.27M(+24.0%) |
| Dec 2014 | -$99.41M(+119.0%) | -$32.23M(+16.8%) | -$99.41M(+16.6%) |
| Sep 2014 | - | -$27.60M(+8.8%) | -$85.28M(+37.7%) |
| Jun 2014 | - | -$25.37M(+78.5%) | -$61.95M(+21.4%) |
| Mar 2014 | - | -$14.21M(-21.5%) | -$51.03M(+12.4%) |
| Dec 2013 | -$45.40M(+69.3%) | -$18.09M(+323.1%) | -$45.40M(+36.2%) |
| Sep 2013 | - | -$4.28M(-70.4%) | -$33.34M(-7.7%) |
| Jun 2013 | - | -$14.45M(+68.5%) | -$36.12M(+31.8%) |
| Mar 2013 | - | -$8.58M(+42.1%) | -$27.40M(+9.6%) |
| Dec 2012 | -$26.81M(-187.7%) | -$6.03M(-14.5%) | -$25.00M(+31.8%) |
| Sep 2012 | - | -$7.06M(+23.1%) | -$18.96M(+59.3%) |
| Jun 2012 | - | -$5.73M(-7.1%) | -$11.91M(+92.9%) |
| Mar 2012 | - | -$6.17M | -$6.17M |
| Dec 2011 | $30.58M | - | - |
FAQ
- What is PTC Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for PTC Therapeutics?
- What is PTC Therapeutics annual EBIT year-on-year change?
- What is PTC Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for PTC Therapeutics?
- What is PTC Therapeutics quarterly EBIT year-on-year change?
- What is PTC Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for PTC Therapeutics?
- What is PTC Therapeutics TTM EBIT year-on-year change?
What is PTC Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PTCT is -$196.13M
What is the all time high annual EBIT for PTC Therapeutics?
PTC Therapeutics all-time high annual earnings before interest & taxes is $30.58M
What is PTC Therapeutics annual EBIT year-on-year change?
Over the past year, PTCT annual earnings before interest & taxes has changed by +$370.80M (+65.41%)
What is PTC Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PTCT is $963.92M
What is the all time high quarterly EBIT for PTC Therapeutics?
PTC Therapeutics all-time high quarterly earnings before interest & taxes is $963.92M
What is PTC Therapeutics quarterly EBIT year-on-year change?
Over the past year, PTCT quarterly earnings before interest & taxes has changed by +$1.01B (+2297.62%)
What is PTC Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PTCT is $811.66M
What is the all time high TTM EBIT for PTC Therapeutics?
PTC Therapeutics all-time high TTM earnings before interest & taxes is $811.66M
What is PTC Therapeutics TTM EBIT year-on-year change?
Over the past year, PTCT TTM earnings before interest & taxes has changed by +$1.31B (+261.32%)